# Commission Decision of 11 April 2006 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2006 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2006) 1483) (Only the Danish, Dutch, English, Estonian, Finnish, French, German, Italian, Slovenian, Spanish and Swedish texts are authentic) (Text with EEA relevance) (2006/540/EC), Annex I

Extent: E+W+S+N.I.

Pursuant to paragraph 3 of Decision XII/2 of the Twelfth Meeting of the Parties to the Montreal Protocol on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (MDIs), the following countries have determined that, due to the presence of suitable non-CFC MDIs, CFCs no longer qualify as ‘essential’ under the Protocol when combined with following active ingredients:
Table 1
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country
Short-acting Beta Agonist Bronchodilators
Salbutamol
Terbutaline
Fenoterol
Orciprenaline
Reproterol
Carbuterol
Hexoprenaline
Pirbuterol
Clenbuterol
Bitolterol
Procaterol
Austria
X
X
X
X
X
X
X
X
X
X
X
Belgium
X
X
X
X
X
X
X
X
X
X
X
Cyprus
X
Czech Republic
X
X
X
X
X
X
X
X
X
X
X
Denmark
X
X
X
X
X
X
X
X
X
X
Estonia
X
X
X
X
X
X
X
X
X
X
X
Finland
X
France
X
Germany
X
X
X
X
X
X
X
X
X
X
X
Greece
X
X
X
X
X
X
X
X
X
X
X
Hungary
X
X
X
X
X
X
X
X
X
X
X
Ireland
X
Italy
X
Latvia
X
X
X
X
X
X
X
X
X
X
X
Lithuania
X
X
X
X
X
X
X
X
X
X
X
Luxembourg
X
Malta
X
Netherlands
X
X
X
X
X
X
X
X
X
X
X
Poland
X
Portugal
X
X
X
X
X
X
X
X
X
X
X
Norway
X
X
X
X
X
X
X
X
X
X
X
Slovak Republic
X
X
X
X
X
X
X
X
X
X
X
Slovenia
X
X
X
X
X
X
X
X
X
X
X
Spain
X
Sweden
X
United Kingdom
X
Table 2
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country
Inhaled steroids
Beclomethasone
Dexamethasone
Flunisolide
Fluticasone
Budesonide
Triamcinolone
Austria
Belgium
X
X
X
X
X
X
Cyprus
Czech Republic
X
X
X
X
X
X
Denmark
X
X
Estonia
X
X
X
X
X
X
Finland
X
X
France
X
X
Germany
X
X
X
X
X
X
Greece
Hungary
X
X
X
X
X
X
Ireland
X
X
Italy
X
X
X
Latvia
X
X
X
X
X
X
Lithuania
Luxembourg
Malta
X
X
Poland
Portugal
X
X
Netherlands
X
X
X
X
X
X
Norway
Slovak Republic
X
X
X
X
X
X
Slovenia
X
X
X
X
X
X
Spain
X
X
Sweden
X
X
X
X
X
United Kingdom
X
Table 3
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country
Non-steroidal anti-inflammatories
Cromoglicic acid
Nedrocromil
Austria
Belgium
X
X
Cyprus
Czech Republic
X
X
Denmark
X
X
Estonia
X
X
Finland
X
X
France
X
X
Germany
X
X
Greece
X
X
Hungary
Ireland
Italy
Latvia
X
X
Lithuania
Luxembourg
Malta
Poland
Portugal
X
Netherlands
X
X
Norway
Slovak Republic
X
X
Slovenia
X
X
Spain
X
Sweden
United Kingdom
Table 4
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country
Anticholinergic Bronchodilators
Ipratropium bromide
Oxitropium Bromide
Austria
Belgium
X
X
Cyprus
X
X
Czech Republic
X
X
Denmark
X
X
Estonia
X
X
Finland
X
X
France
Germany
X
X
Greece
X
X
Hungary
X
X
Ireland
X
X
Italy
Latvia
Lithuania
Luxembourg
Malta
X
X
Netherlands
X
X
Poland
Portugal
X
Norway
Slovak Republic
X
X
Slovenia
Spain
X
X
Sweden
X
X
United Kingdom
X
X
Table 5
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country
Long-acting Beta Agonist Bronchodilators
Formoterol
Salmeterol
Austria
Belgium
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
X
X
Greece
Hungary
Ireland
Italy
X
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Norway
Slovak Republic
Slovenia
Spain
Sweden
United Kingdom
Table 6
Source: www.unep.org/ozone/Information_for_the_Parties/3Bi_dec12-2-3.asp
Country
Combinations of active ingredients in a single MDI
Austria
Belgium
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
X
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Norway
Slovak Republic
Slovenia
Spain
Sweden
United Kingdom

---
Source: https://www.legislation.gov.uk/eudn/2006/540/annex/I (the official version)
Page: https://openlegislation.uk/eu-decision-2006-540/annex-I
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.